Mylan Can't Move Sanofi's EpiPen Antitrust Suit
A New Jersey federal judge on Wednesday denied EpiPen maker Mylan's motion to move to Kansas a lawsuit alleging that it offered rebates to insurers that refused to cover a competing...To view the full article, register now.
Already a subscriber? Click here to view full article